12-5043981-C-T

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4BP6_Very_StrongBA1

The NM_002234.4(KCNA5):​c.-167C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.411 in 691,452 control chromosomes in the GnomAD database, including 61,242 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.44 ( 15301 hom., cov: 33)
Exomes 𝑓: 0.40 ( 45941 hom. )

Consequence

KCNA5
NM_002234.4 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.61

Publications

15 publications found
Variant links:
Genes affected
KCNA5 (HGNC:6224): (potassium voltage-gated channel subfamily A member 5) Potassium channels represent the most complex class of voltage-gated ino channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. Four sequence-related potassium channel genes - shaker, shaw, shab, and shal - have been identified in Drosophila, and each has been shown to have human homolog(s). This gene encodes a member of the potassium channel, voltage-gated, shaker-related subfamily. This member contains six membrane-spanning domains with a shaker-type repeat in the fourth segment. It belongs to the delayed rectifier class, the function of which could restore the resting membrane potential of beta cells after depolarization and thereby contribute to the regulation of insulin secretion. This gene is intronless, and the gene is clustered with genes KCNA1 and KCNA6 on chromosome 12. Defects in this gene are a cause of familial atrial fibrillation type 7 (ATFB7). [provided by RefSeq, May 2012]
KCNA5 Gene-Disease associations (from GenCC):
  • atrial fibrillation, familial, 7
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial atrial fibrillation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.13).
BP6
Variant 12-5043981-C-T is Benign according to our data. Variant chr12-5043981-C-T is described in ClinVar as Benign. ClinVar VariationId is 309329.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.599 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNA5NM_002234.4 linkc.-167C>T 5_prime_UTR_variant Exon 1 of 1 ENST00000252321.5 NP_002225.2 P22460-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNA5ENST00000252321.5 linkc.-167C>T 5_prime_UTR_variant Exon 1 of 1 6 NM_002234.4 ENSP00000252321.3 P22460-1

Frequencies

GnomAD3 genomes
AF:
0.439
AC:
66650
AN:
151990
Hom.:
15282
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.538
Gnomad AMI
AF:
0.242
Gnomad AMR
AF:
0.448
Gnomad ASJ
AF:
0.410
Gnomad EAS
AF:
0.617
Gnomad SAS
AF:
0.557
Gnomad FIN
AF:
0.438
Gnomad MID
AF:
0.325
Gnomad NFE
AF:
0.359
Gnomad OTH
AF:
0.402
GnomAD4 exome
AF:
0.404
AC:
217709
AN:
539344
Hom.:
45941
Cov.:
7
AF XY:
0.409
AC XY:
115866
AN XY:
283476
show subpopulations
African (AFR)
AF:
0.549
AC:
7469
AN:
13606
American (AMR)
AF:
0.431
AC:
8949
AN:
20768
Ashkenazi Jewish (ASJ)
AF:
0.400
AC:
5811
AN:
14522
East Asian (EAS)
AF:
0.560
AC:
17514
AN:
31266
South Asian (SAS)
AF:
0.545
AC:
26375
AN:
48376
European-Finnish (FIN)
AF:
0.437
AC:
12996
AN:
29748
Middle Eastern (MID)
AF:
0.381
AC:
838
AN:
2200
European-Non Finnish (NFE)
AF:
0.360
AC:
125825
AN:
349794
Other (OTH)
AF:
0.411
AC:
11932
AN:
29064
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
6964
13928
20892
27856
34820
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1734
3468
5202
6936
8670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.439
AC:
66708
AN:
152108
Hom.:
15301
Cov.:
33
AF XY:
0.444
AC XY:
33001
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.538
AC:
22338
AN:
41514
American (AMR)
AF:
0.448
AC:
6859
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.410
AC:
1421
AN:
3470
East Asian (EAS)
AF:
0.617
AC:
3168
AN:
5136
South Asian (SAS)
AF:
0.558
AC:
2684
AN:
4812
European-Finnish (FIN)
AF:
0.438
AC:
4635
AN:
10588
Middle Eastern (MID)
AF:
0.322
AC:
94
AN:
292
European-Non Finnish (NFE)
AF:
0.360
AC:
24437
AN:
67974
Other (OTH)
AF:
0.402
AC:
851
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1916
3832
5747
7663
9579
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
610
1220
1830
2440
3050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.378
Hom.:
18047
Bravo
AF:
0.440
Asia WGS
AF:
0.579
AC:
2009
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Sep 06, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Atrial fibrillation, familial, 7 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.13
CADD
Benign
18
DANN
Benign
0.96
PhyloP100
1.6
PromoterAI
-0.036
Neutral
Mutation Taster
=292/8
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3741930; hg19: chr12-5153147; API